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Abstract
Recently, proteomics has emerged as an important tool for understanding 
biological systems, protein–protein interactions, and networks that ultimately lead 
to a deeper understanding of the underlying mechanisms of certain diseases. More 
recently, the study of secretomes, a type of proteomics, has also been highlighted 
as a potential next step in the field of diagnosis/prognosis. The secretome is the 
set of proteins expressed by an organism and secreted into the extracellular space, 
comprising 13–20% of all proteins. Since almost all, if not all, organs produce sec-
retomes, this means that it is possible to study secretomes and trace these proteins 
back to their origin, supporting the idea that this could indeed be very important 
in diagnosing certain diseases. This is often combined with techniques such as mass 
spectrometry to measure the secretome of, for example, a particular tissue, and 
bioinformatics tools and databases to give us an idea of what to expect (prediction). 
In this paper, we will give a general overview of this world, but with a focus on the 
new bioinformatics tools and databases, their advantages and disadvantages, as well 
as a deeper look at isolation systems for proteomes, specifically salivary secretomes. 
Indeed, the salivary secretome represents a valuable new tool capable of providing 
insights into immunopathology and potentially aiding in diagnostics. Furthermore, 
we will explore applications of these methods and give an idea of what the future 
holds for such promising techniques: Salivary secretome in conjunction with bio-
informatics tools/databases in the diagnosis of diseases (such as diabetes, Sjogren’s 
syndrome, and cardiovascular disease).
Keywords: Saliva, bioinformatic tools, prediction
1. Introduction
Salivary plasma is also known as ultrafiltrate of biological fluid. Nearly 1,000 
different proteins and 19,000 unique peptide sequences have been found in saliva. 
Whole saliva (WMS) is a combination of various secretions produced by major and 
minor salivary glands, gingiva cervical fluid (GCF), mucosal transmission, oral 
wound serum and blood vessels [1].
Saliva is mainly composed of three main pairs of salivary glands, namely the 
parotid gland, the sublingual gland, and the lingual gland. Saliva is composed of 
99.5% water, 0.3% protein and 0.2% trace elements. The concentration of proteins 
and peptides in saliva is very important for the maintenance of oral health and 
homeostasis. The increased frequency and severity of oral diseases are often related 
to changes in salivary protein content [2, 3]. Salivary proteins facilitate food percep-
tion and digestion, maintain the integrity of mineralized tooth and oral epithelial 
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surfaces, shield the oral digestive tract from environmental hazards and invading 
pathogens, and protect oral tissues from fungal or viral infections [4, 5]. Moreover, 
it is suggested that the origins of salivary proteins can be analyzed throughout 
mixed saliva and that post-transcriptional modifications may play a key role in 
understanding secretome network pathways [6, 7]. Moreover, Feizi et al., 2020 [7] 
found that the study of secretion pathways (translocation, folding, trafficking and 
glycosylation) is relevant to know tissue-specific secretion pathways and tissue-
specific secretomes that would facilitate the elaboration of a link between proteins 
and diseases.
Salivary gland secretome represents a valuable new tool to measure many local 
soluble mediators to gain future insight into immunopathology and potentially 
aid in diagnosis [8]. This method could be of use to identify therapeutic targets 
and develop markers for stratification, prognosis and treatment response in 
patients [9, 10].
Biomarkers are defined as biological molecules found in blood, saliva, and 
other body fluids, as symptoms of normal or abnormal processes, or symptoms of 
conditions or diseases. Few studies have demonstrated the relationship between 
serum and saliva levels of clinically used biomarkers. Nevertheless, human saliva 
has attracted attention as a liquid biopsy for the diagnosis of oral diseases as a 
potential target. Salivary biomarkers are used for evaluation, prediction and 
diagnosis of various diseases. They can be collected rapidly in a non-invasive, 
natural and painless way. Salivary research can help identify biomarkers associated 
with health and disease conditions [1, 11, 12]. Collection and storage of saliva is 
also simple, relatively cheap and low risk for patients and healthcare professionals 
[3, 13, 14]. Salivary proteomics is a promising tool as proteomic molecules control 
the direct antibacterial action of microorganisms in the oral cavity, but has limita-
tions including non-applicability in the driest patients and technical challenges such 
as the degradation of cytokines by salivary enzymes [9]. Optimization of existing 
histology protocols to determine salivary gland inflammation will help improve the 
diagnosis of various diseases [9, 10].
2. Definition
Under both normal and pathological conditions, cells secrete a variety of pro-
teins into the extracellular space via classical and non-classical secretory pathways 
[5]. The majority of these proteins represent the pathophysiology of the cell from 
which they are secreted. Recently, although more than 92% of protein-coding genes 
have been mapped by the Human Proteome Map Project, a large number of these 
proteins that constitute the cell’s secretome is still unknown [4].
Secreted proteins or the secretome may be accessible in body fluids and are 
therefore considered as potential biomarkers to distinguish between healthy and 
diseased individuals [8]. To facilitate biomarker discovery and further assist clini-
cians and scientists working in these areas, we compiled and cataloged secreted 
proteins from the human proteome using an integrated bioinformatics approach 
[9, 10]. In this study, it was found that nearly 14% of the human proteome is likely 
secreted via classical and non-classical secretion pathways. Of these, ~38% of these 
secreted proteins were found in extracellular vesicles including exosomes and shed-
ding microvesicles.
Of these secreted proteins, 94% were detected in human body fluids including 
blood, plasma, serum, saliva, semen, tears, and urine. We hypothesize that this 
list of secreted proteins with high confidence could serve as a compendium of 




into understanding the molecular mechanisms involved in various physiological 
and pathophysiological conditions.
The highly elevated inflammatory mediators in the secretions of patients with 
complex diseases such as primary Sjögren’s syndrome (PSS) are related to clinical 
parameters.
2.1 Secreted proteins
A secreted protein can be defined as a protein that is actively transported outside 
the cell. In humans, cells such as endocrine cells and B lymphocytes are specialized 
in the secretion of proteins, most cells secrete proteins in different. Not only is this 
a rich source of new treatments and drug targets, but most of the blood diagnostic 
tests used in the clinic target secreted proteins, underscoring the importance of 
these proteins to medicine and biology. These include pancreatic enzymes (PRSS1, 
CELA3A, AMY2A) and other digestive enzymes expressed in the salivary glands 
(PRR4, STATH, ZG16B) or stomach (PGA3, PGA4). The liver is one of the most 
important secretory organs and produces high amounts of plasma proteins such 
as albumin, fibrinogen and transferrin. Another group of highly secreted proteins 
belongs to the diphenhydramine family and is secreted by glandular cells in the 
epididymis (DEFB118, DEFB106A and DEFB129).
2.2 Membrane proteins
Membrane proteins are one of the largest and most important classes of pro-
teins. Membrane proteins are associated with cell membranes or organs in cells 
and can be classified as peripheral or integrated. Peripheral membrane proteins 
bind to the membrane by binding to the peripheral region of the membrane or by 
integrated membrane proteins, but cannot completely penetrate the membrane. 
Integrated membrane proteins have a hydrophobic α-helical or β-barrel structure so 
that they can be distributed throughout the lipid molecule and linked by the outer 
loop region of the membrane. The α-helical integral membrane protein is the main 
type of membrane protein and is found in all types of biological membranes. This 
explains why their key roles as transporters and receptors currently account for 
about 57% of approved drug targets, as they are of great importance to the pharma-
ceutical industry. Many important receptors and cell surface molecules are found 
in the list of human cell differentiation molecules (CD markers). The G protein 
synthesis receptor (GPCR) comprises seven transmembrane fragments (DM) and 
contains 775 human protein-coding genes, making it the largest membrane pro-
tein target.
2.3 Classification of the human proteome
Despite the availability of the human salivary proteome, the origin of individual 
proteins remains unclear. So far, more than 3000 proteins have been identified in 
various studies, and with new tools and methods, more will be identified [4].
Meinken et al., 2015 [15] analyzed the subcellular location of the protein using 
MetazSecKB. The subcellular location of the protein is an important factor that 
determines the function of the protein molecule in the organism. MetazSecKB is 
a knowledge base for subcellular proteins developed specifically for metazoans 
(i.e., humans and animals). More than 4 million protein sequence data entries have 
been retrieved from UniProt, including 121 complete proteins. The location of 
protein subgroups, including secretion and 15 subgroup sites, are assigned based on 
selected test evidence or predictions using 7 computational tools [15].
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Various identifiers, gene names, keywords and types can be used to search and 
download protein or subcellular protein data. Support BLAST search and com-
munity annotation of sublocalizations. Our preliminary analysis shows that protein 
levels, secretome levels, and other subcellular protein levels vary widely among 
different animal species. Confidentiality levels range from 3–22% (mean 8%) in 
Metazzoa species [15].
Approximately 21–43% (mean 31%) in cytoplasm, 20–37% (mean 30%) in 
embryo, 3–19% (mean 12%) plasma membrane proteins and 3–9% (mean 6%) in 
mitochondria. The authors also compared protein families in different animal spe-
cies [15]. Genetic oncology of human secreted proteins and field analysis of protein 
families show that these proteins play an important role in the development of 
human structure, signal transduction and regulation of many biological processes 
in the immune system [15].
The combination of the results of membrane protein and secretion analysis 
draws the distribution map of potential membrane proteins and secreted proteins 
in human membrane proteins. Three types are used to annotate the protein isoforms 
of all human genes: (i) secreted type, (ii) membrane type, and (iii) endogenous 
type (i.e., proteins with no predictable SP/TM properties). Note that proteins 
classified as membranous may be localized in the endoplasmic reticulum or in the 
inner membrane, such as the colon. Each human protein-coding gene is classified 
as having all isoforms encoding protein isoforms belonging to one or two or three 
types of these groups. The results showed that at least 36% of the predicted human 
genes contain membrane-disseminated or secreted protein isoforms.
2.4 The plasma proteome
Plasma is the transparent, liquid part of blood that is formed when white blood 
cells, red blood cells, and platelets are removed. It consists of small substances such 
as water (90%), protein (7–8%), salt, gas, and nutrients. Plasma proteins contain 
up to 90% of the ten most abundant proteins, including albumin, fibrinogen, which 
is involved in blood clotting, and immunoglobulin, which is mainly involved in 
immune processes. One of the most important functions of plasma is to transport 
essential compounds to different parts of the body, regulate osmotic pressure and 
fluid exchange in all tissues, and play an important role in immune system func-
tion. Most cells in the body interact with plasma directly or indirectly through other 
fluids. Therefore, analysis of plasma proteins can provide important information 
about the patient’s health status.
The dynamic range of plasma protein between the high albumin (ALB) con-
centration is more than 10 orders of magnitude. It has an extraordinary dynamic 
range. It can serve as a transporter and helps maintain the osmotic pressure of 
emulsification. Rare proteins containing interleukins are found in tissues. Although 
many proteins in the plasma proteome pass through the secretory pathway, there is 
another type of tissue-secreted proteins that are found in cells but can be released 
into plasma due to cell death or damage. There is also an interesting class of proteins 
that do not enter the ER/Golgi pathway by non-classical secretion and include 
cytokines such as interleukin 10 (IL10) and mitogens such as fibroblast growth 
factor 2 (FGF2).
2.5 The secretory pathway
In the secretory pathway, the signal sequence protein travels from the endoplas-




sequence that drives protein secretion is called a signal peptide. It is a short 
 hydrophobic N-terminus that is inserted into the ER membrane and separated 
from the protein. In most cases, the N-terminal transmembrane (TM) acts as part 
of the signal line. The ER signal sequence is recognized by the chaperone protein, 
which guides the ribosome to the approximate ER where transfer of the protein 
sequence takes place in a protein complex called the translocon. The membrane 
protein is transferred by the translocation protein to the lipid player of the ER 
membrane, and the secreted protein is transferred into the lumen of ER. Proteins 
that pass the quality control of ER are transported by vesicles to the Golgi, where 
they are further modified in important processes such as glycosylation and phos-
phorylation. The Golgi is also responsible for sorting proteins for transport to their 
final destination. These proteins are usually plasma membranes, lysosomes or cell 
secretions.
3. Systems for isolation
With the use of novel advanced technologies, many oral and systemic diseases 
can be treated early with non-invasive, easy to follow, time-saving and personalized 
solutions, further enhancing the potential of salivary secretome [16].
3.1 Common methods used to identify salivary secretome
Salivary secretome mainly includes proteins, metabolites, genes, microorgan-
isms and immune system. Various methods are used to analyze molecules to study 
and verify biomarkers. Proteins can be used to diagnose diabetes, periodontitis, 
dental caries and AIDS [16, 17]. However, salivary transcriptome and genes include 
mRNA and DNA. Genetic chip sequencing, DNA hybridization, qPCR and gel 
electrophoresis help in identifying various diseases. On the other hand, metabolic 
research requires and uses gas chromatography–mass spectrometry, nuclear mag-
netic resonance spectroscopy and high-performance liquid chromatography. These 
methods can be used to diagnose diabetes, lung cancer, pancreatic cancer, breast 
cancer and Sjogren’s syndrome [17, 18].
3.2 Saliva biomarker-based platforms
The analysis system is based on different technologies used to detect biomarkers 
in saliva. Single and multiple systems (e.g. MEMS, ORI, chromatographic test strips 
and multiple salivary glands (US)) are only used to detect proteins and whole pro-
teins and nucleic acids (e.g. IL -8, MMP-8, α-amylase, e.g. IV, HCV) up to 1 minute 
[19], and there is a short time limit. Therefore, these technologies have reduced the 
aggressive behavior to a higher level [19].
3.3 Novel isolation techniques
Biosensor is a biological analyzer that can replicate any biological material. The 
biosensor works by biometrically identifying specific components and is designed 
for target analysis. They remain selective and sensitive to the presence of other 
interfering compounds. In the medical field, the application of biosensors is grow-
ing rapidly [20, 21]. They can detect antibodies/antigens, nucleic acids, cell struc-




3.4 Automated mass spectrometry-based approach
Using liquid chromatography–tandem mass spectrometry (LC -MS/MS) to iden-
tify novel targets in specially prepared cell secretions, Wetie et al., 2013 [22] have 
developed an automated, simple and effective strategy. In addition, the support-
ing role of mass spectrometry (MS) in the functional evaluation of the identified 
secreted targets is investigated [22].
Simplicity is achieved by culturing cells in serum-free medium, which eliminates 
the need to remove large amounts of serum protein while minimizing unsightly 
matrix effects. Once these factors have been determined, their verification and 
nature is followed. In addition, this method can lead to the identification of abnor-
mally secreted, spilled or exaggerated proteins in response to stimuli [22].
3.5 BioMEMS
The lab-on-a-chip system uses small and easy-to-build BioMEMS devices to 
detect biological and chemical agents. They are based on micro/nano scale fabrica-
tion systems and help to improve the sensitivity of sensor results. It has unlabeled 
detection technology including microconverter, surface plasmon oscillation and 
organic field effect transistors [23, 24].
Biological Micro-Electro-Mechanical Systems (MEMS) can be used in many 
applications, such as drug delivery, heart MEMS, hearing aids, insulin microbumps, 
endoscopic lens agents, and retinal prostheses for monitoring patients with heart 
disease [25].
3.6 Fluorescent biosensors
Fluorescent biosensors can be used in cancer, drug development, arthritis, 
cardiovascular and viral infections, chronic myeloid leukemia, etc. Efficient 
screening methods, applications of fluorescence studies in gene expression, protein 
location in cell cycle, cell apoptosis, signal transduction and transcription [26]. 
Nanomaterials and nanoproducts for biosensors offer opportunities for the next 
generation of biosensing. They can be widely used for monitoring, diagnosis, 
control and analysis [27].
3.7 Electrical field-induced release and measurement (EFIRM)
The liquid biopsy technique called EFIRM uses electrochemical methods to 
promote hybridization of nucleic acids [28]. This method enables precise detection of 
RNA and protein biomarker targets on exosomes. EFIRM can analyze mutation status 
within one hour without extracting DNA. It can detect cancer in oral cavity cancer, 
non-squamous lung cancer and epidermal growth factor (EGFR) mutations [29].
3.8 Microfluidics
Microfluidic applications work with integrated micromachining and specific 
physical and chemical properties. Originally, silicone, mineral glass and ceram-
ics were used. These materials were replaced by soft and hard thermostatic and 
thermoplastic materials or biodegradable hydrogel materials.
The paper analytical device (μPADs) was first developed by Whiteside. Paper 
is microscopic and hydrophilic, so it provides the basis for the formation of micro-
scopic channels. They are used to diagnose urine metabolism, blood glucose, pH, 




4. Interaction with other systems
Saliva is a potential diagnostic tool that can provide a simple diagnostic method. 
The presence of salivary biomarkers can aid in early diagnosis. Saliva has the poten-
tial to revolutionize next-generation molecular testing. It can diagnose oral cancer, 
dental inflammation and periodontitis [31]. To date, many salivary biomarkers have 
been proposed for the diagnosis of oral cancer. Conventional medical standards are 
not sufficient to easily determine the location of active disease or to easily measure 
the progress of future disease. Genetic testing offers the most effective way to 
prevent dental disease in the long term [31–33].
In addition, several research groups have reported the use of whole saliva or 
glandular saliva for mass spectrometry-based proteomics research. The extensive 
enumeration of salivary proteins is done by combining the previous LC -MS/MS 
-based saliva research data with our research data [34].
Using the bioinformatics tools mentioned above, a possible analysis of gene 
ontology classification and their secretion was performed. Comparing with the lat-
est human salivary proteins synthesized from oral cancer tissues expressing differ-
ent proteins, we found proteins associated with oral cancer. The protein peptides of 
these proteinsor the most observed peptides were selected from the Global Protein 
Machine Database (GPMDP) [35].
5. Bioinformatics tools for secretome prediction
Proteins can flow from blood to salivary glands by active transport, passive 
diffusion, or ultrafiltration, and then some of them are released into saliva, so if 
accurately identified, they can be used as biomarkers of disease [36]. Researchers 
have developed a series of novel computational and biological communication tools 
to predict salivary biomarkers [37].
The basis of the prediction is a set of physicochemical and hierarchical features 
found between human proteins that can pass from blood to saliva and proteins 
that are not present in saliva [36, 37]. In 2013, Wang et al., [38] predicted human 
salivary proteins from blood and evaluated their use in identifying diagnostic 
biomarkers. This predictive capability can be used to predict potential biomarker 
proteins for specific human diseases, information about various exposed proteins 
in diseased and healthy control tissues, and the prognostic potential of proteins 
secreted in blood. This enables the use of antibody-based technology to target 
effective biomarkers in saliva. They used this comprehensive data to predict that 31 
candidate biomarker proteins in saliva could be used in breast cancer [38].
5.1 Bioinformatic tools
Continued method development supports the comprehensive identification and 
quantification of secreted proteins at specific cellular levels. The role of secretory 
factors in regulating important signaling events has been discussed, and a con-
nectivity diagram has been constructed to describe differential secretory expression 
and dynamic changes [39].
Bioinformatics has become a bridge between confidential data and computer 
tasks to manage, mine and retrieve information. Based on this information, predic-
tions can be made to help clarify the physiological state of a particular organism 
and determine the specific dysfunction at the stage of disease. The major challenge 
in data analysis lies within the integration of biological information from different 
sources. Database enhancements and software improvements can greatly increase 
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the practicality and reliability of confidential investigations [39]. Reliable data inter-
pretation is essential for the formation and exploration of relevant disease biomarker 
proposals as well as the discovery of new drug targets. Using genetic oncology (GO), 
it is possible to collect basic information about secretome proteins. GO analysis can 
determine how the identified components relate to specific functions or processes 
and whether a particular type of protein is found in secretions. In addition, in a sta-
tistical framework, the method GO can determine whether there is an obvious GO 
period [40]. In the database GO, molecular functions are defined as the biochemical 
functions of gene products. The biological pathway refers to the integration of the 
biochemical properties of proteins. Pathway analysis is an important step to properly 
understand the uniqueness and function of secrets. Methods have been developed to 
assess whether protein packaging is present in the target phenotype. Using differ-
ent tools, according to different group rules, can provide different and sometimes 
complementary information. The results are strongly influenced by the criteria 
chosen to define the target protein and the reference list [40, 41].
Ingenuity Path Analysis (IPA) and Meta Core (Genico) are commercial software 
for visualizing high performance data in a biological network environment. STRING 
is a free database of known and predicted protein interactions, including direct 
(physical) and indirect (functional) associations from various sources [42]. In this 
way, the network of protein–protein interaction, metabolism or genetic regulation 
can be reconstructed based on prior knowledge and the biological network can be 
reconstructed. Determined by the interaction between its components [42, 43].
Pathway analysis tools become very popular and can interpret omics data 
quickly. To date, IPA has been highly cited in the field of proteomics, having 
been used in 121 publications. The software is designed to interpret large genetic 
datasets, but it can also be used to illustrate the biological implications of complex 
proteomics datasets [43].
Data sharing presents a new challenge for modern proteomics. The first obstacle 
to data sharing is the data format. Each MS tool generates a file from the source data 
in a proprietary format. The HUPO-PSI standard has been accepted by vendors and 
public web-based resource providers. The proteomics community has developed 
guidelines to facilitate storage and open access to proteomics data in a central public 
repository [44–46].
PeptideAtlas, PRIDE and Trench have been developed to share data among the 
entire proteomics research community [47–49]. Recently, the Proteome Change 
Alliance has established a place where MS proteomics data can be submitted to 
the existing major proteomics databases. The purpose is to facilitate data transfer 
between them to achieve the best data transfer and to create a global accession 
number for all participating databases. This information will be available to all MS/
MS researchers in the UK who wish to use it for their research [47–49].
Using the innovative majority voting methods, Rehman et al., 2020, analyzed 
transcriptome data from 5 cancer types and more than 3000 samples to measure 
the relative difference in gene expression of secretory proteins compared to normal 
tissue in the vicinity. A comprehensive, in-depth data mining analysis reveals that 
among several cancer types, a continuous group of uncontrolled secretory protein 
subtypes is concentrated in hematopoietic cell lines. Genes associated with hemato-
poietic cell lineages are often reduced during the continuous development of cancer, 
and high exposure levels are associated with good prognosis for patients [50].
Moreover, they suggest that cancer cells suppress the underlying mechanism of 
hematopoietic cell lineage signaling by reducing the expression of immune-related 
genes. The data identify potential biomarkers for cancer immunotherapy. It can 
be concluded that this method is applicable to define other cancers and highlight 




5.2 BONCAT and pulsed SILAC
Despite the increasing interest in secretomes associated with paracrine/auto-
crine mechanisms, mass spectrometric cell studies have been performed using 
serum-free media (SFM). On the other hand, the use of serum culture medium 
(SCM) is not necessarily recommended because secretions obtained with SCM are 
easily contaminated with fetal serum proteins (FBS) [51].
Shin et al., 2019, [51] used biological non-designated amino acid tags 
(BONCAT) and pulsed SILAC (pSILAC) to analyze the different secreted proteins 
between SFM and SCM. Mesenchymal stem cells are derived from human cancer 
cells U87MG and human Wharton’s Jelly (hWJ-MSCs) [51]. In most cases, the 
biological communication equipment predicts that the protein is secreted when the 
protein secretion level in SCM is higher than in SFM. In HWJ-MSC, the amount of 
protein secreted in SCM within 24 hours, even considering different cell prolifera-
tion rates, is greater than SFM [51]. The highly secreted HWJ-MSC protein in SCM 
contains many positive markers of angiogenesis, neurogenesis and osteogenesis, as 
well as MSc-paracrine factors involved in upstream regulators of cell proliferation. 
This result indicates that secretome analysis should be processed in SCM to promote 
cell proliferation and secretion [51].
Another computational method was evaluated by Min, 2010 [52] to understand 
the prediction accuracy of signal B, phobia, target B and wolf sport, which can be 
used alone or in combination with DMHMM and PS scanning. Prediction accuracy 
is represented by Mathews Correlation Coefficient (MCC). Tools for predicting pro-
teins secreted in different eukaryotic kingdoms show different advantages. Using 
his own tools, the author found Wolfsport for fungi (73.1%), Phobius for animals 
(82.8%), Signal B for plants (55.4%) and Phobius for proteases (42.1%) [52].
The use of TMHMM significantly improves the prediction accuracy of all data-
sets. According to the measured accuracy, it is recommended to use the following 
methods to make secret predictions for different eukaryotes: signal P/DMHM/wolf-
port/Phobius/PS scan for fungi (83.4%), Phobius/wolfb/animal/PS -86A Phobius/
target P/PS scan (73.2%), combined with all tools for protists (52.8%) [52].
Free interactive resources are provided within the portal Human Protein Atlas 
(www.proteinatlas.org) and analyzed by Uhlén et al., 2015 [53]. The portal offers the 
possibility to explore tissue-expressed proteins in tissues and organs and to analyze tis-
sue profiles for specific protein classes. A large list of proteins expressed at high levels 
in different tissues was compiled to localize the protein in the subunits of each tissue 
and organ and provide a spatial environment down to the level of individual cells [53].
6. Applications
Saliva is a complex fluid containing various enzymes, electrolytes, proteins, 
nucleic acids, antibacterial components, hormones, cytokines, and antibodies. Its 
composition almost reflects the overall state of physical health and disease. It can 
become a diagnostic tool for many diseases. The submandibular saliva of patients 
with cystic fibrosis contains 66% more lipids per 100 milliliters of saliva than 
healthy substances. Salivary fatty acid profile can be used as a good indicator for 
early detection of heart disease. Dietary fat intake influences the increased arachi-
donic acid production associated with lung inflammation and heart disease.
Under normal and pathological conditions, cells secrete various types of proteins 
into the extracellular space via classical and nonclassical secretory pathways. Most 
of these proteins represent cell secretion pathologies. Recently, Human Protein 
Atlas Project has localized more than 92% of protein-coding genes, but the number 
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of proteins secreted by cells is still difficult to determine [54]. Secreted proteins or 
secretions can enter body fluids and are therefore considered as potential biomark-
ers to distinguish healthy and diseased individuals. To facilitate the discovery of 
biomarkers and to further assist physicians and scientists working in this field, 
Keerthikumar et al., 2016, [54] used integrated bioinformatics methods to compile 
and list the secreted proteins in humans.
In this study, it was found that about 14% of human proteins can be secreted 
through classical and non-classical secretion pathways. Among them, about 38% of 
secreted proteins are in extracellular cells, including exosomes and excretory microor-
ganisms. Of these secreted proteins, 94% are present in human body fluids, including 
blood, plasma, serum, saliva, semen, tears, and urine [54]. The author hypothesizes 
that this list of secreted proteins can serve as a set of candidate biomarkers with high 
confidence. They can provide functional insights to understand the molecular mecha-
nisms associated with various physiological and pathophysiological states of cells [54].
Chen et al., 2019, [55] found that secretory proteins are widely expressed in vari-
ous tissues and body fluids, and a large proportion of them are expressed in a tissue-
specific manner. In addition, there are 14 cancer-related secretory proteins. Their 
expression levels are significantly correlated with survival rates of patients with eight 
different tumors, which may be potential prognostic biomarkers [55]. Surprisingly, 
of the 6,943 secretory proteins, 89.21% (2,927 novel secretory proteins) have known 
protein domains [55]. The authors enriched these novel secretory proteins mainly 
by known domains related to immunity (such as immunoglobulin V set and C1 set 
domains). Their comprehensive novel secretory proteins and features provide insight 
into human confidentiality and are valuable resources for future research [55].
In Sjogren’s syndrome, salivary flow is impaired due to tubular changes caused 
by lymphocyte infiltration and salivary gland fibrosis, and the patient suffers from 
toothache, infectious dysphagia, and other oral complaints. The blood lipid level 
of Sjogren’s patients is twice that of normal healthy people, and the antibody level 
is high. Patients with Sjogren’s syndrome or radiation therapy for head and neck 
cancer have severe dry mouth, which greatly affects their oral health and qual-
ity of life. Since there is no clinically proven treatment, clinical management of 
xerostomia is limited to preventive treatment. Previous research has shown that 
mesenchymal stem cells (MMSC) derived from mouse bone marrow differ from 
salivary progenitors when grown together with mouse salivary epithelial cells [56]. 
Restrictive transcription factors in co-grown MMSCs are identified with amylase 
(AMY1), muscarinic 3 receptors (M3R), aquaporin 5 (AQP5), tubular morphological 
changes, and acinar cell marker expression [56]. This cell marker is called cytokera-
tin 19 (CK19). Mona et al., 2020, investigated inducible molecules in a conditioned 
medium that can trigger MMSC replication and integrated mass spectrometry and 
systems biology by high performance liquid chromatography. Based on their key 
roles in embryonic development and salivary gland growth, our method identified 
ten differentially expressed proteins [56]. In addition, systems biology analysis 
revealed six candidate proteins, namely cysteine-rich insulin-like growth factor 
binding protein 7 (IgFPP7), pro-angiogenic stimulant 61 (CYR61), acrin (AGRN), 
laminin, beta 2 (LAMP2), folistatin 1 (FSDL1) and fibronectin 1 (FN1), all of which 
could potentially contribute to the propagation of MMSC during co-cultivation [56].
Human salivary secretome plays a diagnostic role in the diagnosis of heart dis-
ease. Diabetes is another common disease that is rapidly developing worldwide. Due 
to its non-invasiveness, cheap and simple saliva samples are attractive as diagnostic 
fluids for diabetes analysis. The announced study concluded that various biomark-
ers are used in the early stages to diagnose diabetes. Compared to serum of diabetic 
and diabetic patients, salivary glucose, amylase, calcium, phosphorus and calcium 




Salivary secretome test requires proper identification and verification of bio-
markers. Diagnosis and biomarkers are measurable parameters that can interact 
physiologically and biochemically at the molecular or cellular level and always 
serve as normal indicators. The pathology and intervention behavior of the human 
body can be identified using biomarkers present in salivary secretome. Biomarkers 
include many categories, such as protein, DNA, RNA, metabolism and microorgan-




BIOCARTA Protein-pathway association B https://maayanlab-cloud/
Harmonizome/dataset/
Biocarta+Pathways




DisGeNET Gene and variability associated 
with disease
B https://www.disgenet.org/
Gene Ontology Computational model of 
biological systems (genes)
A http://geneontology.org/
GPM Proteomics data analysis, reuse 
and validation for biological 
and biomedical research
C https://www.thegpm.org/




KEGG Database of high-level 
functions on biological systems
C https://www.genome.jp/kegg/
Meta Core Omics analysis B https://portal.genego.com/




Panther Biological pathways B http://www.pantherdb.org/




PeptideAtlas MS/MS peptide data B http://www.peptideatlas.org/
Philius Signal peptide prediction A http://www.yeastrc.org/philius/
pages/philius/runPhilius.jsp
Phobius Signal peptide prediction B http://phobius.sbc-su.se/
PRIDE Proteomics datasets B http://www.ebi-ac.uk/pride/




SignalP Signal peptide prediction A http://www.cbs.dtu.dk/services/
SignalP/
STRING Protein–protein interaction 
networks
A https://string-db.org/




UniProt Protein database B http://www.uniprot.org/
Wolfpsort Subcellular localization 
prediction
B https://wolfpsort.hgc.ip/
A - easy to use and accessible, B - accessible but hard to use, C - hard to access and use.
Table 1. 




With our current results, we note that although the secretome has gained 
attention and has been highlighted in recent studies, it is still of interest to explore 
this topic more deeply. In future studies, we propose to go beyond the usual protein 
profiling and perform network studies to find links between proteins from salivary 
secretome in direct and indirect ways. In addition, studies have begun to evaluate 
the role that transcriptional and post-transcriptional modifications of proteins have 
in informing their origin [6, 7]. This will be relevant for establishing links between 
salivary protein levels and disease prognosis/diagnosis.
In Figure 1, we see a flowchart of the information presented in this paper. 
Starting from a secretome: how do we detect it (detection approach), how do we 
identify it (protein identification), how do we verify information about these pro-
teins (record repositories and inventory of the secretome). This line of work leads 
to the analysis of the secretome, but makes up only part of the pipeline. Prediction 
tools are also of great use (genomic datasets enable the existence of tools to predict 
secretory proteins). Several of the bioinformatics tools discussed previously can be 
used to perform secretome analysis, where we can limit the investigation to protein 
Figure 1. 
Workflow of secretome analysis for the comprehensive characterization of molecules secreted by salivary glands, 




profiling, but also go beyond that to investigate signaling pathways, networks (pro-
tein–protein, gene-protein, protein-disease), and determine useful disease biomark-
ers. All of this information culminates in getting closer to the biological significance 
of certain proteins and interactions under certain circumstances. Figure 1 shows 
several examples of biomarkers mentioned in this review and narrows that down to 
applications for saliva testing, namely in areas such as prognosis and diagnosis. In 
summary, Figure 1 represents the pipeline and workflow of secretome studies.
8. Conclusion
Although there are some limitations, salivary proteomics is a promising diag-
nostic and therapeutic tool for several critical diseases. Salivary gland secretome 
represents a valuable new tool to measure many local soluble mediators, provide 
future insight into immunopathology, and potentially aid in diagnosis.
Routine laboratory tests include hematology, clinical chemistry, and immu-
nochemistry using high performance equipment. Diagnosis based on salivary 
secretome may provide an efficient, rapid and simple automated method for trans-
formation. The next decade will bring improvements in accuracy, performance, and 
bed monitoring, but not hospital systems.
Improving basic healthcare systems with personalized medications, biosensors, 
lab-on-a-chip systems, personal genetics, and smartphone tracking parameters. The 
impact of saliva testing on healthcare systems is enormous, aggressive and convenient.
Reportedly, the ability to use saliva for a liquid biopsy is an important diagnostic 
tool for medical conditions and dental diseases. The simple model has information 
related to non-aggression and physical health, making it an attractive choice.
Some of the salivary secretome markers mentioned in this review are general 
markers, not specific to particular diseases. A more specific set of markers is needed 
to make salivary secretome an acceptable diagnostic fluid. The recent introduction 
of the programmable bio-nanochip system (P-PNC) has driven the revolution in 
saliva detection technology for the detection of cardiovascular disease (CVD).
Other biosensing systems, such as cardiac microelectromechanical systems 
(MEMS), can also be used to detect certain diseases. With the help of the latest labs 
in chip systems, they will improve hospital practice and human health [57]. Future 
development of this diagnostic tool will lead to further improvements in certain 
devices that will change the method of screening for critical diseases such as CVD.
Figure 2. 
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A take-home message that summarizes, as shown in Figure 2, the main issues 
that have been addressed so far in salivary proteomics as a diagnostic and therapeu-
tic tool. It also includes the means of detection and prediction of salivary pro-
teomics (biosensors and bioinformatics tools). Although some have been used for 
a long time, most are novel tools and techniques that have been shown to provide 
great data to support proteomics studies. In addition, Figure 2 provides a short list 
of the most promising and relevant salivary biomarkers discussed to date.
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